Pure Global

Test for Myoglobin - India CDSCO Medical Device Registration

Test for Myoglobin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000203_2c3578bb9523abebd7c2e24810826821_7beec2fe63ff95ade2d05868f197ca5c. This device is marketed under the brand name QDx Instacheck™ Cortisol. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Test for Myoglobin
UID: IMP/MD/2018/000203_2c3578bb9523abebd7c2e24810826821_7beec2fe63ff95ade2d05868f197ca5c

Brand Name

QDx Instacheck™ Cortisol

Device Class

Class B

Approving Authority

CDSCO

Product Information

QDx Instacheck™ Myoglobin along with QDx Instacheck™ Reader is a fluorescence Immunoassay (QDx Instacheck™ Cortisol) for the quantitative determination of Myoglobin in human whole blood/ serum/plasma. It is useful as an aid in management and monitoring of acute myocardial infarction (QDx Instacheck™ Cortisol)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing